NeoGenomics (NASDAQ:NEO – Get Free Report) and Sonida Senior Living (NYSE:SNDA – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, profitability and analyst recommendations.
Valuation and Earnings
This table compares NeoGenomics and Sonida Senior Living”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| NeoGenomics | $727.33 million | 3.00 | -$108.03 million | ($0.40) | -42.45 |
| Sonida Senior Living | $381.14 million | 4.99 | -$70.78 million | ($6.19) | -6.39 |
Insider & Institutional Ownership
98.5% of NeoGenomics shares are owned by institutional investors. Comparatively, 87.5% of Sonida Senior Living shares are owned by institutional investors. 1.1% of NeoGenomics shares are owned by company insiders. Comparatively, 39.3% of Sonida Senior Living shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Volatility and Risk
NeoGenomics has a beta of 1.74, suggesting that its stock price is 74% more volatile than the S&P 500. Comparatively, Sonida Senior Living has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500.
Profitability
This table compares NeoGenomics and Sonida Senior Living’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| NeoGenomics | -6.77% | -1.99% | -1.21% |
| Sonida Senior Living | -23.27% | -25.53% | -6.67% |
Analyst Recommendations
This is a summary of recent recommendations and price targets for NeoGenomics and Sonida Senior Living, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| NeoGenomics | 1 | 2 | 7 | 1 | 2.73 |
| Sonida Senior Living | 1 | 2 | 5 | 0 | 2.50 |
NeoGenomics currently has a consensus target price of $16.71, indicating a potential downside of 1.56%. Sonida Senior Living has a consensus target price of $47.50, indicating a potential upside of 20.07%. Given Sonida Senior Living’s higher probable upside, analysts clearly believe Sonida Senior Living is more favorable than NeoGenomics.
Summary
NeoGenomics beats Sonida Senior Living on 10 of the 15 factors compared between the two stocks.
About NeoGenomics
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
About Sonida Senior Living
Sonida Senior Living, Inc. develops, owns, operates, and manages senior housing communities in the United States. The company provides independent living services, which include daily meals, transportation, social and recreational activities, laundry, housekeeping, and 24-hour staffing; and access to health screenings, periodic special services, and dietary and similar programs, as well as exercise and fitness classes. It also offers assisted living services consist of personal care services, such as assistance with activities of daily living, including ambulation, bathing, dressing, eating, grooming, personal hygiene, and monitoring or assistance with medications; support services, such as meals, assistance with social and recreational activities, laundry, general housekeeping, maintenance, and transportation services; and supplemental services, which include extra transportation, personal maintenance, and extra laundry services, as well as special care services for residents with various forms of dementia. In addition, the company provides memory care services; and home care services through third-party providers. As of December 31, 2021, it operated 75 senior housing communities in 18 states with an aggregate capacity of approximately 9,500 residents, including 60 senior housing communities. The company was formerly known as Capital Senior Living Corporation and changed its name to Sonida Senior Living, Inc. in November 2021. Sonida Senior Living, Inc. was founded in 1990 and is based in Addison, Texas.
Receive News & Ratings for NeoGenomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeoGenomics and related companies with MarketBeat.com's FREE daily email newsletter.
